Transcriptomics

Dataset Information

0

BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma

ABSTRACT: To clarify the role of BEX2, we analyzed the differential gene expressions between BEX2 knock down cells and control.

ORGANISM(S): Homo sapiens

PROVIDER: GSE136741 | GEO | 2020/12/16

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.
| S-EPMC7725823 | biostudies-literature
Genomics BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma
| PRJNA563555 | ENA
Unknown Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma.
| S-EPMC7053328 | biostudies-literature
Unknown Asbestos and Intrahepatic Cholangiocarcinoma.
| S-EPMC7072580 | biostudies-literature
Unknown Intrahepatic cholangiocarcinoma: current perspectives.
| S-EPMC5328612 | biostudies-literature
Unknown Management of Intrahepatic Cholangiocarcinoma.
| S-EPMC8198953 | biostudies-literature
Unknown Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
| S-EPMC7381674 | biostudies-literature
Unknown MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression.
| S-EPMC5471004 | biostudies-literature
Unknown Intrahepatic cholangiocarcinoma: expert consensus statement.
| S-EPMC4527852 | biostudies-literature
Unknown Therapeutic options for intrahepatic cholangiocarcinoma.
| S-EPMC5411274 | biostudies-literature